Results 231 to 240 of about 67,271 (245)

Absolute neutrophil count as a diagnostic guide for the use of MRI in the workup of suspected appendicitis in children

Journal of Pediatric Surgery, 2019
Timothy Lautz, Cynthia Rigsby, Tolulope Oyetunji   +2 more
exaly  

Reporting Sysmex XN Absolute Neutrophil Count in Samples with Leukocyte Analyzer Flagging

Laboratory Medicine, 2021
exaly  

Hospital Absolute Neutrophil Count Reference Intervals and Specificity of the Population Served

Mayo Clinic Proceedings
Lucas T. Go, Lewis T. Go, Madugodaralalage D.S.K. Gunaratne, Grant M. Spears, Jithma P. Abeykoon   +4 more
openaire   +2 more sources

#792 Comparison of manual vs. automated leukocyte counts for determination of the absolute neutrophil count

Journal of Pediatric Hematology/Oncology, 1999
D. M. Parham, P. North, C. Quiggins, R. Ready, C. Stine, D. Becton   +5 more
openaire   +1 more source

#52 Comparison of manual vs. automated leukocyte counts for determination of the absolute neutrophil count

Journal of Pediatric Hematology/Oncology, 1999
D. M. Parham, P. North, C. Quiggins, R. Ready, C. Stine, D. Becton   +5 more
openaire   +1 more source

Calculated decisions: Absolute neutrophil count

Emergency medicine practice, 2018
openaire   +1 more source

Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects

Clinical Drug Investigation, 2013
Joo-Youn Cho, Kwang-Hee Shin, Kyung-Sang Yu   +2 more
exaly  

Average Absolute Neutrophil Count During Maintenance Chemotherapy In Latino Versus Non-Latino Caucasian Patients with Childhood Acute Lymphoblastic Leukemia

Blood, 2010
Naomi Winick, Winick Naomi
exaly  

Serum Pegfilgrastim Concentrations During Recovery of Absolute Neutrophil Count in Patients with Cancer Receiving Pegfilgrastim After Chemotherapy

Pharmacotherapy, 2007
exaly  

Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship

Pediatric Blood and Cancer
Jenny Ruiz, Theodore Laetsch
exaly